Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 4:35 PM View:  | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition (other) | 7,529,950 | -- | -- | (100%) 7.53M to 0 | |
| 24-May-23 4:38 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 22-May-23 | Sale Duplicate | 70,170 | $1.88 | $131,920.00 | (< 1%) 7.6M to 7.53M | |
| 24-May-23 4:38 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 22-May-23 | Exercise (in-the money or at-the-money) Duplicate | 178,269 | $0.74 | $131,919.00 | 2% 7.42M to 7.6M | |
| 01-Aug-22 4:34 PM View: | Allovir, Inc. (ALVR) | 28-Jul-22 | Grant Duplicate | 3,253,800 | $4.61 | $15,000,000.00 | 24% 13.45M to 16.7M | |
| 06-Jan-22 4:12 PM View: | Iteos Therapeutics, Inc. (ITOS) | 05-Jan-22 | Market Sale | 30,347 | $42.03 | $1,275,480.00 | (< 1%) 22.67M to 22.64M | < 1% |
| 06-Jan-22 4:12 PM View: | Iteos Therapeutics, Inc. (ITOS) | 04-Jan-22 | Market Sale | 215,122 | $42.66 | $9,176,850.00 | (< 1%) 22.88M to 22.67M | 2% |
| 10-Feb-23 10:00 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-21 | Option Exercise | 350,938 | $4.30 | $1,509,030.00 | 4% 7.89M to 8.24M | |
| 07-Dec-21 6:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Dec-21 | Market Sale (Planned) | 32,558 | $33.22 | $1,081,700.00 | (< 1%) 42.89M to 42.86M | 3% |
| 07-Dec-21 6:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 06-Dec-21 | Market Sale (Planned) | 17,083 | $32.59 | $556,766.00 | (< 1%) 42.91M to 42.89M | 1% |
| 07-Dec-21 6:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 03-Dec-21 | Market Sale (Planned) | 33,749 | $34.79 | $1,173,960.00 | (< 1%) 42.95M to 42.91M | 8% |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 02-Dec-21 | Market Sale (Planned) | 62,230 | $33.96 | $2,113,190.00 | (< 1%) 34.18M to 34.12M | 2% |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Dec-21 | Market Sale (Planned) | 20,742 | $34.28 | $710,988.00 | (< 1%) 34.2M to 34.18M | 3% |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 30-Nov-21 | Market Sale (Planned) | 56,801 | $35.09 | $1,993,240.00 | (< 1%) 34.26M to 34.2M | 5% |
| 30-Nov-21 4:49 PM View: | Iteos Therapeutics, Inc. (ITOS) | 29-Nov-21 | Market Sale (Planned) | 17,356 | $34.49 | $598,543.00 | (< 1%) 19.88M to 19.86M | < 1% |
| 30-Nov-21 4:49 PM View: | Iteos Therapeutics, Inc. (ITOS) | 26-Nov-21 | Market Sale (Planned) | 21,210 | $35.75 | $758,282.00 | (< 1%) 19.9M to 19.88M | 4% |
| 24-Nov-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Nov-21 | Market Sale (Planned) | 60,808 | $36.29 | $2,206,510.00 | (< 1%) 40.53M to 40.47M | |
| 24-Nov-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Nov-21 | Market Sale (Planned) | 33,476 | $36.22 | $1,212,340.00 | (< 1%) 40.56M to 40.53M | |
| 24-Nov-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Nov-21 | Market Sale (Planned) | 35,333 | $37.52 | $1,325,820.00 | (< 1%) 40.6M to 40.56M | |
| 24-Nov-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 17-Nov-21 | Disposition (other) Duplicate | 15,671 | -- | -- | (< 1%) 40.62M to 40.6M | |
| 18-Oct-21 4:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 18-Oct-21 | Market Sale (Planned) | 10,320 | $27.14 | $280,085.00 | (< 1%) 15.45M to 15.44M | (3%) |
| 18-Oct-21 4:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 15-Oct-21 | Market Sale (Planned) | 18,295 | $27.62 | $505,300.00 | (< 1%) 15.46M to 15.45M | (1%) |
| 14-Oct-21 5:26 PM View: | Iteos Therapeutics, Inc. (ITOS) | 14-Oct-21 | Market Sale (Planned) | 45,719 | $27.30 | $1,248,130.00 | (< 1%) 15.67M to 15.62M | 3% |
| 14-Oct-21 5:26 PM View: | Iteos Therapeutics, Inc. (ITOS) | 13-Oct-21 | Market Sale (Planned) | 35,023 | $27.13 | $950,174.00 | (< 1%) 15.7M to 15.67M | 3% |
| 14-Oct-21 5:26 PM View: | Iteos Therapeutics, Inc. (ITOS) | 12-Oct-21 | Market Sale (Planned) | 14,260 | $27.09 | $386,303.00 | (< 1%) 15.72M to 15.7M | 2% |
| 12-Oct-21 4:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 11-Oct-21 | Market Sale (Planned) | 81,684 | $27.24 | $2,225,070.00 | (< 1%) 16.03M to 15.95M | 2% |
| 12-Oct-21 4:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 08-Oct-21 | Market Sale (Planned) | 3,400 | $27.01 | $91,834.00 | (< 1%) 16.03M to 16.03M | < 1% |
| 12-Oct-21 4:33 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Oct-21 | Market Sale (Planned) | 1,922 | $27.00 | $51,894.00 | (< 1%) 16.04M to 16.03M | < 1% |
| 05-Oct-21 4:31 PM View: | Iteos Therapeutics, Inc. (ITOS) | 04-Oct-21 | Market Sale (Planned) | 34,659 | $27.06 | $937,872.00 | (< 1%) 10.76M to 10.73M | 1% |
| 05-Oct-21 4:31 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Oct-21 | Market Sale (Planned) | 11,471 | $27.00 | $309,717.00 | (< 1%) 10.78M to 10.77M | 1% |
| 30-Sep-21 5:05 PM View: | Iteos Therapeutics, Inc. (ITOS) | 30-Sep-21 | Market Sale (Planned) | 3,836 | $27.00 | $103,572.00 | (< 1%) 10.8M to 10.79M | 5% |
| 30-Sep-21 5:05 PM View: | Iteos Therapeutics, Inc. (ITOS) | 28-Sep-21 | Market Sale (Planned) | 32,154 | $27.00 | $868,158.00 | (< 1%) 10.83M to 10.8M | 5% |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 27-Sep-21 | Market Sale (Planned) | 19,455 | $27.09 | $527,036.00 | (< 1%) 21.82M to 21.8M | (< 1%) |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Sep-21 | Market Sale (Planned) | 8,221 | $27.81 | $228,626.00 | (< 1%) 21.82M to 21.82M | 2% |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Sep-21 | Market Sale (Planned) | 61,800 | $27.97 | $1,728,430.00 | (< 1%) 21.89M to 21.82M | 3% |
| 23-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Sep-21 | Market Sale (Planned) | 23,921 | $27.54 | $658,784.00 | (< 1%) 11.09M to 11.06M | 1% |
| 23-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 21-Sep-21 | Market Sale (Planned) | 32,858 | $27.47 | $902,609.00 | (< 1%) 11.12M to 11.09M | 1% |
| 20-Sep-21 6:30 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Sep-21 | Market Sale (Planned) | 40,673 | $27.49 | $1,117,960.00 | (< 1%) 22.53M to 22.49M | 1% |
| 20-Sep-21 6:30 PM View: | Iteos Therapeutics, Inc. (ITOS) | 17-Sep-21 | Market Sale (Planned) | 76,473 | $28.82 | $2,203,950.00 | (< 1%) 22.6M to 22.53M | 6% |
| 20-Sep-21 5:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 16-Sep-21 | Market Sale (Planned) | 432 | $29.06 | $12,553.90 | (< 1%) 7.9M to 7.9M | 9% |
| 20-Sep-21 5:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 16-Sep-21 | Market Sale (Planned) Duplicate | 3,124 | $29.06 | $90,783.40 | (< 1%) 7.9M to 7.89M | 9% |
| 20-Sep-21 6:30 PM View: | Iteos Therapeutics, Inc. (ITOS) | 16-Sep-21 | Market Sale (Planned) | 35,565 | $28.47 | $1,012,540.00 | (< 1%) 22.64M to 22.6M | 5% |
| 16-Sep-21 4:44 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 15-Sep-21 | Market Sale (Planned) | 888 | $29.16 | $25,894.10 | (< 1%) 7.9M to 7.9M | < 1% |
| 16-Sep-21 4:44 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 15-Sep-21 | Market Sale (Planned) Duplicate | 6,425 | $29.16 | $187,353.00 | (< 1%) 7.9M to 7.9M | < 1% |
| 16-Sep-21 4:44 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 14-Sep-21 | Market Sale (Planned) | 982 | $29.17 | $28,644.90 | (< 1%) 7.91M to 7.91M | < 1% |
| 16-Sep-21 4:44 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 14-Sep-21 | Market Sale (Planned) Duplicate | 7,106 | $29.17 | $207,282.00 | (< 1%) 7.91M to 7.9M | < 1% |
| 13-Sep-21 6:22 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 13-Sep-21 | Market Sale (Planned) | 497 | $29.10 | $14,462.70 | (< 1%) 7.92M to 7.92M | 1% |
| 13-Sep-21 6:22 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 13-Sep-21 | Market Sale (Planned) Duplicate | 3,595 | $29.10 | $104,614.00 | (< 1%) 7.92M to 7.91M | 1% |
| 13-Sep-21 7:02 PM View: | Iteos Therapeutics, Inc. (ITOS) | 13-Sep-21 | Market Sale (Planned) | 35,785 | $27.64 | $989,097.00 | (< 1%) 23.4M to 23.36M | 2% |
| 13-Sep-21 6:22 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 10-Sep-21 | Market Sale (Planned) | 820 | $29.04 | $23,812.80 | (< 1%) 7.92M to 7.92M | < 1% |
| 13-Sep-21 6:22 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 10-Sep-21 | Market Sale (Planned) Duplicate | 5,931 | $29.04 | $172,236.00 | (< 1%) 7.92M to 7.92M | < 1% |